{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:29:30Z","timestamp":1763620170555,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Institutes of Health\/National Institute for Diabetes and Digestive and Kidney Health","award":["F32 DK107111","K23 DK101826-02","R01 DK091565"],"award-info":[{"award-number":["F32 DK107111","K23 DK101826-02","R01 DK091565"]}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1053\/j.ajkd.2016.04.016","type":"journal-article","created":{"date-parts":[[2016,5,29]],"date-time":"2016-05-29T00:01:44Z","timestamp":1464480104000},"page":"628-632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pemetrexed-Induced Nephrogenic Diabetes Insipidus"],"prefix":"10.1053","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8485-3972","authenticated-orcid":false,"given":"Enrica","family":"Fung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuchi","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2016.04.016_bib1","unstructured":"National Cancer Institute at the National Institutes of Health. FDA approval for pemetrexed disodium. http:\/\/www.cancer.gov\/about-cancer\/treatment\/drugs\/fda-pemetrexed-disodium. Accessed August 12,\u00a02015."},{"key":"10.1053\/j.ajkd.2016.04.016_bib2","unstructured":"US Food and Drug Adminstration. Approved drugs: pemetrexed. http:\/\/www.fda.gov\/Drugs\/InformationOnDrugs\/ApprovedDrugs\/ucm324239.htm. Accessed August 12,\u00a02015."},{"issue":"4","key":"10.1053\/j.ajkd.2016.04.016_bib3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1200\/JCO.2004.00.9720","article-title":"Phase I and pharmacokinetic study of pemetrexed administered every 3 weeks to advanced cancer patients with normal and impaired renal function","volume":"24","author":"Mita","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"21","key":"10.1053\/j.ajkd.2016.04.016_bib4","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","article-title":"Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer","volume":"26","author":"Scagliotti","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"21","key":"10.1053\/j.ajkd.2016.04.016_bib5","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1200\/JCO.2003.99.092","article-title":"Thymidine rescue: an antidote for pemetrexed-related toxicity in the setting of acute renal failure","volume":"21","author":"Castro","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1053\/j.ajkd.2016.04.016_bib6","doi-asserted-by":"crossref","first-page":"402","DOI":"10.5414\/CN107921","article-title":"Pemetrexed-induced acute kidney injury leading to chronic kidney disease","volume":"82","author":"Chauvet","year":"2014","journal-title":"Clin Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2016.04.016_bib7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1053\/j.ajkd.2011.04.030","article-title":"Kidney tubular toxicity of maintenance pemetrexed therapy","volume":"58","author":"Glezerman","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2016.04.016_bib8","first-page":"610","article-title":"[Acute renal failure associated with pemetrexed (Alimta)]","volume":"29","author":"Porta","year":"2009","journal-title":"Nefrologia"},{"issue":"1","key":"10.1053\/j.ajkd.2016.04.016_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000208377","article-title":"Acute tubular necrosis and interstitial nephritis during pemetrexed therapy","volume":"2","author":"Michels","year":"2009","journal-title":"Case Rep Oncol"},{"issue":"8","key":"10.1053\/j.ajkd.2016.04.016_bib10","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3109\/0886022X.2010.501930","article-title":"Interstitial nephritis and nephrogenic diabetes insipidus in a patient treated with pemetrexed","volume":"32","author":"Stavroulopoulos","year":"2010","journal-title":"Ren Fail"},{"issue":"3","key":"10.1053\/j.ajkd.2016.04.016_bib11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1385\/MO:23:3:419","article-title":"Pemetrexed-induced acute renal failure, nephrogenic diabetes insipidus, and renal tubular acidosis in a patient with non-small cell lung cancer","volume":"23","author":"Vootukuru","year":"2006","journal-title":"Med Oncol"},{"issue":"20","key":"10.1053\/j.ajkd.2016.04.016_bib12","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2008.20.8181","article-title":"Phase II study of pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer","volume":"27","author":"Patel","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"34","key":"10.1053\/j.ajkd.2016.04.016_bib13","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1200\/JCO.2012.47.9626","volume":"31","author":"Patel","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1053\/j.ajkd.2016.04.016_bib14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1053\/j.ajkd.2016.04.016_bib15","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1210\/jc.2012-1981","article-title":"Clinical review: current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review","volume":"97","author":"Fenske","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1053\/j.ajkd.2016.04.016_bib16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jama.1963.03060090031011","article-title":"A\u00a0water deprivation test for the differential diagnosis of polyuria","volume":"185","author":"Dashe","year":"1963","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2016.04.016_bib17","unstructured":"Eli Lilly. Eli Lilly and Company: 2013 Annual Report. http:\/\/www.lilly.com\/pdf\/lillyar2013.pdf. Accessed December 3,\u00a02015."},{"issue":"suppl 9","key":"10.1053\/j.ajkd.2016.04.016_bib18","doi-asserted-by":"crossref","first-page":"ix69","DOI":"10.1093\/annonc\/mdt460.16","article-title":"Renal toxicity of pemetrexed in patients with non small-cell lung cancer","volume":"24","author":"Inoue","year":"2013","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1053\/j.ajkd.2016.04.016_bib19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1124\/dmd.114.059618","article-title":"Prediction of renal transporter mediated drug-drug interactions for pemetrexed using physiologically based pharmacokinetic modeling","volume":"43","author":"Posada","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1053\/j.ajkd.2016.04.016_bib20","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1124\/mol.108.045443","article-title":"The proton-coupled folate transporter: impact on pemetrexed transport and on antifolates activities compared with the reduced folate carrier","volume":"74","author":"Zhao","year":"2008","journal-title":"Mol Pharmacol"},{"issue":"7","key":"10.1053\/j.ajkd.2016.04.016_bib21","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2215\/CJN.02050309","article-title":"Renal vulnerability to drug toxicity","volume":"4","author":"Perazella","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2016.04.016_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1200\/JCO.1999.17.1.409","article-title":"Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin","volume":"17","author":"Go","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1053\/j.ajkd.2016.04.016_bib23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/ki.1985.90","article-title":"Effect of cisplatin on the transepithelial potential difference of rat distal tubule","volume":"27","author":"Allen","year":"1985","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2016.04.016_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2369-7-10","article-title":"Gitelman-like syndrome after cisplatin therapy: a case report and literature review","volume":"7","author":"Panichpisal","year":"2006","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2016.04.016_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MJT.0b013e31829c4c71","article-title":"Clinical predictors associated with proton pump inhibitor-induced hypomagnesemia","volume":"22","author":"Kim","year":"2015","journal-title":"Am J Ther"},{"issue":"4, pt 2","key":"10.1053\/j.ajkd.2016.04.016_bib26","first-page":"F657","article-title":"Bilateral ureteral obstruction downregulates expression of vasopressin-sensitive AQP-2 water channel in rat kidney","volume":"270","author":"Frokiaer","year":"1996","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1053\/j.ajkd.2016.04.016_bib27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.ackd.2013.06.010","article-title":"Tubulointerstitial injury associated with chemotherapeutic agents","volume":"21","author":"Shirali","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"issue":"9","key":"10.1053\/j.ajkd.2016.04.016_bib28","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1158\/0008-5472.CAN-03-3953","article-title":"Selective preservation of pemetrexed pharmacological activity in HeLa cells lacking the reduced folate carrier: association with the presence of a secondary transport pathway","volume":"64","author":"Zhao","year":"2004","journal-title":"Cancer Res"},{"issue":"11","key":"10.1053\/j.ajkd.2016.04.016_bib29","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1681\/ASN.2014111067","article-title":"Deep sequencing in microdissected renal tubules identifies nephron segment-specific transcriptomes","volume":"26","author":"Lee","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2016.04.016_bib30","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jama.281.9.824","article-title":"Postmarketing surveillance and adverse drug reactions: current perspectives and future needs","volume":"281","author":"Brewer","year":"1999","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2016.04.016_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1152\/ajplegacy.1965.208.1.38","article-title":"Effect of Osmotic Diuresis on Intrarenal Solutes in Diabetes Insipidus and Hydropenia","volume":"208","author":"Appelboom","year":"1965","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1053\/j.ajkd.2016.04.016_bib32","doi-asserted-by":"crossref","first-page":"F34","DOI":"10.1152\/ajprenal.0101.2001","article-title":"Reduced expression of Na-K-2Cl cotransporter in medullary TAL in vitamin D-induced hypercalcemia in rats","volume":"282","author":"Wang","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1053\/j.ajkd.2016.04.016_bib33","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1038\/ki.1996.539","article-title":"Extracellular calcium-sensing receptor: implications for calcium and magnesium handling in the kidney","volume":"50","author":"Hebert","year":"1996","journal-title":"Kidney Int"},{"issue":"8","key":"10.1053\/j.ajkd.2016.04.016_bib34","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1172\/JCI118628","article-title":"Hypokalemia-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla and cortex","volume":"97","author":"Marples","year":"1996","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1053\/j.ajkd.2016.04.016_bib35","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1681\/ASN.2005040371","article-title":"Molecular biology of hereditary diabetes insipidus","volume":"16","author":"Fujiwara","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2016.04.016_bib36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ajmg.1320380120","article-title":"Autosomal recessive inheritance of vasopressin-resistant diabetes insipidus","volume":"38","author":"Langley","year":"1991","journal-title":"Am J Med Genet"},{"issue":"7","key":"10.1053\/j.ajkd.2016.04.016_bib37","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJM198402163100707","article-title":"Transient vasopressin-resistant diabetes insipidus of pregnancy","volume":"310","author":"Barron","year":"1984","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1053\/j.ajkd.2016.04.016_bib38","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/ndt\/gfi111","article-title":"Urinary endothelin-1 as a marker of renal damage in sickle cell disease","volume":"20","author":"Tharaux","year":"2005","journal-title":"Nephrol Dial Transplant"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638616301226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638616301226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:46:51Z","timestamp":1759459611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638616301226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0272638616301226"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2016.04.016","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pemetrexed-Induced Nephrogenic Diabetes Insipidus","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2016.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}